Related Experiment Video
Updated: Mar 15, 2026

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis
Published on: January 30, 2020
Targeted Disruption of Chlamydia trachomatis Invasion by in Trans Expression of Dominant Negative Tarp Effectors
Christopher J Parrett1, Robert V Lenoci1, Brenda Nguyen1
1Division of Immunology and Pathogenesis, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida Orlando, FL, USA.
Abstract:
Chlamydia trachomatis invasion of eukaryotic host cells is facilitated, in part, by the type III secreted effector protein, Tarp. The role of Tarp in chlamydiae entry of host cells is supported by molecular approaches that examined recombinant Tarp or Tarp effectors expressed within heterologous systems. A major limitation in the ability to study the contribution of Tarp to chlamydial invasion of host cells was the prior absence of genetic tools for chlamydiae. Based on our knowledge of Tarp domain structure and function along with the introduction of genetic approaches in C. trachomatis, we hypothesized that Tarp function could be disrupted in vivo by the introduction of dominant negative mutant alleles. We provide evidence that transformed C. trachomatis produced epitope tagged Tarp, which was secreted into the host cell during invasion. We examined the effects of domain specific Tarp mutations on chlamydial invasion and growth and demonstrate that C. trachomatis clones harboring engineered Tarp mutants lacking either the actin binding domain or the phosphorylation domain had reduced levels of invasion into host cells. These data provide the first in vivo evidence for the critical role of Tarp in C. trachomatis pathogenesis and indicate that chlamydial invasion of host cells can be attenuated via the introduction of engineered dominant negative type three effectors.
Insights
Chlamydia trachomatis uses the Tarp protein to invade host cells. Genetic engineering of Tarp mutants reduced bacterial invasion, offering new therapeutic strategies against Chlamydia infections.
Area of Science:
- Microbiology
- Cell Biology
- Pathogenesis
Background:
- Chlamydia trachomatis invasion relies on the type III secreted effector protein, Tarp.
- Previous studies used recombinant systems, limited by a lack of genetic tools for Chlamydia.
Purpose of the Study:
- To investigate the in vivo role of Tarp in Chlamydia trachomatis invasion using dominant-negative mutant alleles.
- To assess the impact of specific Tarp domain mutations on bacterial entry and intracellular growth.
Main Methods:
- Engineered dominant-negative Tarp mutants in Chlamydia trachomatis.
- Utilized epitope-tagged Tarp to confirm secretion into host cells during invasion.
- Assessed invasion and growth of mutant strains in host cells.
Main Results:
- Transformed Chlamydia trachomatis successfully produced and secreted epitope-tagged Tarp.
- Mutants lacking the actin-binding or phosphorylation domains showed reduced host cell invasion.
- Demonstrated in vivo evidence for Tarp's critical role in pathogenesis.
Conclusions:
- Tarp is essential for efficient Chlamydia trachomatis invasion of host cells.
- Engineered dominant-negative Tarp effectors can attenuate Chlamydia invasion, suggesting potential therapeutic applications.

